Solicitation of Nominations for Membership on the National Vaccine Advisory Committee, 26238-26240 [2016-10205]

Download as PDF 26238 Federal Register / Vol. 81, No. 84 / Monday, May 2, 2016 / Notices regarding the burden estimate, below, or any other aspect of the ICR. DATES: Comments on the ICR must be received on or before July 1, 2016. ADDRESSES: Submit your comments to Information.CollectionClearance@ hhs.gov or by calling (202) 690–6162. FOR FURTHER INFORMATION CONTACT: Information Collection Clearance staff, Information.CollectionClearance@ hhs.gov or (202) 690–6162. SUPPLEMENTARY INFORMATION: When submitting comments or requesting information, please include the document identifier HHS–OS–0990– New—60D for reference. Information Collection Request Title: Evaluation of the Second Decade Project Community Planning Guide Abstract: The Office of the Assistant Secretary for Health (OASH) is requesting approval from the Office of Management and Budget (OMB) for an evaluation of the Second Decade Project Community Planning Guide. OASH has a long history of collaborating with communities to improve adolescent health outcomes. To further help communities build an environment that promotes adolescent health, OASH recently developed Promoting Health and Healthy Development in the Second Decade of Life: A Planning Guide for Communities (‘‘the Guide’’). The purpose of the Guide is to provide an easy to follow tool that community leaders can use to (1) establish a community coalition with broad membership, and (2) develop a community plan for improving adolescent health and well-being that includes multi-impact strategies. To understand whether and how community leaders are able to use the Guide to achieve these two goals, OASH needs information about the Guide’s utility and effectiveness. The evaluation of the Second Decade Project Community Planning Guide (‘‘the evaluation’’) is intended to support the goals of OASH’s Second Decade Project of helping community leaders incorporate the needs of children, adolescents and young adults in community growth and development plans, and to improve outcomes of young adults and adolescents. Five communities will participate in the piloting and evaluation of the Guide. The evaluation will provide OASH with critical information regarding the components of the Guide that community leaders found most useful and effective in accomplishing their goals of improving adolescent health and wellbeing; the compilation and inclusiveness of the coalitions implementing the Guide; and the demographic and environmental context of these communities. While secondary data will be collected from sources such as the U.S. Census Bureau American Community Survey and Youth Risk Behavior and National Health Interview Surveys, these sources do not provide nuanced information needed by OASH to understand the contexts in which the Guide is most effective. Likely Respondents—Qualitative data will be collected through semistructured telephone interviews and through focus groups. Telephone interviews will be conducted with community leaders (Community Leader Interview) in the five pilot sites to explore how the use of the Guide supported key leaders in their development of a diverse coalition and educating the community about issues facing adolescents. Focus groups will be conducted with coalition members (Coalition Member Focus Groups) from the five pilot sites to assess how the Guide facilitated the work of the coalition to develop a comprehensive community plan that addresses critically important adolescent health issues. Quantitative data will be collected through Web-based surveys with coalition members from the five communities and with secondary stakeholders—specifically, adolescent health experts and state/local health department officials—selected by OASH. The Coalition Assessment Survey will assess coalition members’ perspectives on the usefulness and ease of implementing the Guide. The Secondary Stakeholder Survey will engage Adolescent Health researchers and practitioners to garner additional feedback and assessment of the Guide. TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of responses per respondent Number of respondents Form name Hours per response Total burden hours 50 80 250 50 1 1 1 1 1 1 .25 .5 50 80 63 25 Total ........................................................................................................ srobinson on DSK5SPTVN1PROD with NOTICES Community Leader Interview (CLI) ................................................................ Coalition Member Focus Group (CFG) ......................................................... Coalition Assessment Survey (CAS) ............................................................. Secondary Stakeholder Survey (SSS) .......................................................... 430 .......................... ........................ 218 OASH specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DEPARTMENT OF HEALTH AND HUMAN SERVICES Terry S. Clark, Asst. Information Collection Clearance Officer. Solicitation of Nominations for Membership on the National Vaccine Advisory Committee [FR Doc. 2016–10199 Filed 4–29–16; 8:45 am] BILLING CODE 4150–28–P National Vaccine Program Office, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: 42 U.S.C. 300aa–5, Section 2105 of the Public Health Service (PHS) Act, as amended. The National Vaccine AUTHORITY: VerDate Sep<11>2014 20:30 Apr 29, 2016 Jkt 238001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\02MYN1.SGM 02MYN1 srobinson on DSK5SPTVN1PROD with NOTICES Federal Register / Vol. 81, No. 84 / Monday, May 2, 2016 / Notices Advisory Committee (NVAC) is governed by the provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. SUMMARY: The National Vaccine Program Office (NVPO), a program office within the Office of the Assistant Secretary for Health, Department of Health and Human Services (HHS), is soliciting nominations of qualified candidates to be considered for appointment as public members to the NVAC. The activities of this Committee are governed by the Federal Advisory Committee Act (FACA). Management and support services of the NVAC and its activities are the responsibility of the NVPO. The NVAC serves an advisory role, providing recommendations to the Assistant Secretary for Health in his/her capacity as the Director of the National Vaccine Program, on matters related to the Program’s responsibilities. Specifically, the Committee studies and recommends ways to encourage the availability of an adequate supply of safe and effective vaccination products in the United States; and recommends research priorities and other measures to enhance the safety and efficacy of vaccines. The Committee also advises the Assistant Secretary for Health in the implementation of Sections 2102 and 2103 of the PHS Act; and identifies annually the most important areas of government and non-government cooperation that should be considered in implementing Sections 2102 and 2103 of the PHS Act. DATES: All nominations for membership on the Committee must be received no later than 5:00 p.m. EDT on June 1, 2016, to the address listed below. ADDRESSES: Hardcopy nominations should be mailed or delivered to: Bruce Gellin, M.D., M.P.H., Executive Secretary, NVAC, Office of the Assistant Secretary for Health, Department of Health and Human Services, 200 Independence Avenue SW., Room 715–H, Washington, DC 20201. Electronic nominations should be emailed to nvpo@hhs.gov. FOR FURTHER INFORMATION CONTACT: Jennifer Gordon, Ph.D., Alternate Designated Federal Official, NVAC; Science Advisor, National Vaccine Program Office, Department of Health and Human Services, 200 Independence Avenue SW., Room 733G, Washington, DC 20201; (202) 260–6619; Jennifer.Gordon@hhs.gov. A copy of the Committee charter which includes the NVAC’s structure and functions, as well as a list of the VerDate Sep<11>2014 20:30 Apr 29, 2016 Jkt 238001 current membership, can be obtained by contacting Dr. Gordon or by accessing the NVAC Web site at: www.hhs.gov/ nvpo/nvac. SUPPLEMENTARY INFORMATION: Committee Function, Qualifications, and Information Required: As part of an ongoing effort to enhance deliberations and discussions with the public on vaccine and immunization policy, nominations are being sought for interested individuals to serve on the NVAC. Committee members provide peer review, consultation, advice, and recommendations to the Assistant Secretary for Health, in his/her capacity as the Director of the National Vaccine Program, on matters related to the Program’s responsibilities. Individuals selected for appointment to the NVAC will serve as voting members. The NVAC consists of 17 voting members: 15 public members, including the Chair, and two representative members. Individuals selected for appointment to the NVAC can be invited to serve terms of up to four years. Selection of members is based on candidates’ qualifications to contribute to the accomplishment of NVAC’s objectives. Interested candidates should demonstrate a willingness to commit time to NVAC activities and the ability to work constructively and effectively on committees. Public Members: Public members are individuals who are appointed to the NVAC to exercise their own independent, best judgment on behalf of the government. It is expected that public members will discuss and deliberate in a manner that is free from conflicts of interest. Public members to the NVAC shall be selected from individuals who are engaged in vaccine research or the manufacture of vaccines, or who are physicians, members of parent organizations concerned with immunizations, representatives of state or local health agencies, or public health organizations. Representative Members: Representative members are individuals who are appointed to the NVAC to provide the views of industry or a special interest group. While they may be experts in various topic areas discussed by the Committee, they should not present their own viewpoints, but rather those of the industry or special interest group they represent. NVAC representative members shall serve specifically to represent the viewpoints or perspectives of the vaccine manufacturing industry or groups engaged in vaccine research or the manufacture of vaccines. This announcement is to solicit nominations of qualified candidates to PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 26239 fill positions in the public member category of the NVAC, including positions that are scheduled to be vacated during the 2016 calendar year. Travel reimbursement and compensation for services provided to the committee: All voting NVAC members, public and representatives, are authorized to receive the prescribed per diem allowance and reimbursement for travel expenses that are incurred to attend meetings and conduct authorized NVAC-related business, in accordance with standard government travel regulations. Members appointed to the NVAC as public members (see definition above) also are authorized to receive a stipend for services provided at public meetings of the Committee. All other services that are performed by the public members outside the Committee meetings shall be provided without compensation. Representative members (see definition above) will serve without compensation. Expertise sought for the National Vaccine Advisory Committee: In accordance with the charter, persons nominated for appointment as members of the NVAC should be among authorities knowledgeable in areas related to vaccine safety, vaccine effectiveness, and vaccine supply. In order to enhance the diversity of expertise included in Committee discussions, NVPO is seeking nominations of individuals to serve on the NVAC as public members in the following disciplines/topic areas: • Vaccine research and development, vaccine clinical trials, and vaccine regulatory science; • vaccine safety and post-marketing surveillance; • vaccine access and financing; • health information technologies and immunization information systems; • immunization program implementation and management; • vaccine communications; How to submit nominations: Nominations should be typewritten. The following information is required to be included in the package of material submitted for each individual being nominated for consideration: (1) A letter of nomination that clearly states the name and affiliation of the nominee, the basis for the nomination (i.e., specific attributes which qualify the nominee for service in this capacity); and a statement that the nominee is willing to serve as a member of the Committee (2) the nominator’s name, address and daytime telephone number, home and/or work address, telephone number, and email address; (3) a copy of the nominee’s current curriculum vitae (no longer than ten pages); and (4) a short biographical E:\FR\FM\02MYN1.SGM 02MYN1 26240 Federal Register / Vol. 81, No. 84 / Monday, May 2, 2016 / Notices srobinson on DSK5SPTVN1PROD with NOTICES sketch (no more than 350 words). All required documentation must be received in order for a nomination to be considered. Please note that nominees will not receive updates on the status of their nomination. Information on nominees appointed to the Committee by the Department will be posted to the NVAC Web site (https://www.hhs.gov/ nvpo/nvac/roster/). Individuals can nominate themselves for consideration of appointment to the Committee. All nominations must include the required information. Incomplete nominations will not be processed for consideration. The names of federal employees should not be nominated for consideration of appointment to this Committee. The Department makes every effort to ensure that the membership of HHS federal advisory committees is fairly balanced in terms of points of view represented and the committee’s function. Every effort is made that a broad representation of geographic areas, gender, ethnic and minority groups, and the disabled are given consideration for membership on HHS federal advisory committees. Appointment to this Committee shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, disability, and cultural, religious, or socioeconomic status. Individuals appointed to serve as public members of federal advisory committees are classified as special government employees (SGEs). SGEs are government employees for purposes of the conflict of interest laws. Therefore, individuals appointed to serve as public members of NVAC are subject to an ethics review. The ethics review is conducted to determine if the individual has any interests and/or activities in the private sector that may conflict with performance of their official duties as a member of the NVAC. Individuals appointed to serve as public members of the NVAC will be required to disclose information regarding financial holdings, consultancies, research grants and/or contracts, and the absence of an appearance of a loss of impartiality. Dated: April 25, 2016. Bruce Gellin, Executive Secretary, National Vaccine Advisory Committee Deputy Assistant Secretary for Health, Director, National Vaccine Program Office. [FR Doc. 2016–10205 Filed 4–29–16; 8:45 am] BILLING CODE 4150–44–P VerDate Sep<11>2014 20:30 Apr 29, 2016 Jkt 238001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Council on Alcohol Abuse and Alcoholism. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council on Alcohol Abuse and Alcoholism. Date: June 9, 2016. Closed: 9:00 a.m. to 10:00 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Terrace Conference Rooms, 5635 Fishers Lane, Rockville, MD 20892. Open: 10:15 a.m. to 4:00 p.m. Agenda: Presentations and other business of the council. Place: National Institutes of Health, Terrace Conference Rooms, 5635 Fishers Lane, Rockville, MD 20892. Contact Person: Abraham P. Bautista, Ph.D., Executive Secretary, National Institute on Alcohol Abuse & Alcoholism, National Institutes of Health, 5635 Fishers Lane, Room 2085, Rockville, MD 20852, 301–443–9737, bautista@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.niaaa.nih.gov/AboutNIAAA/ AdvisoryCouncil/Pages/default.aspx, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants; 93.701, ARRA Related Biomedical Research and Research Support Awards., National Institutes of Health, HHS) Dated: April 26, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–10145 Filed 4–29–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications/ contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications/ contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Development of Protein Standards. Date: May 31, 2016. Time: 1:00 p.m. to 2:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W114, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, 9609 Medical Center Drive, Room 7W238, Bethesda, MD 20892–9750, 240–276–6371, decluej@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Member Conflict SEP. Date: June 27, 2016. Time: 11:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Room 7W530, Rockville, MD 20850 (Telephone Conference Call). E:\FR\FM\02MYN1.SGM 02MYN1

Agencies

[Federal Register Volume 81, Number 84 (Monday, May 2, 2016)]
[Notices]
[Pages 26238-26240]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-10205]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Solicitation of Nominations for Membership on the National 
Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

AUTHORITY: 42 U.S.C. 300aa-5, Section 2105 of the Public Health Service 
(PHS) Act, as amended. The National Vaccine

[[Page 26239]]

Advisory Committee (NVAC) is governed by the provisions of Public Law 
92-463, as amended (5 U.S.C. Appendix 2), which sets forth standards 
for the formation and use of advisory committees.

SUMMARY: The National Vaccine Program Office (NVPO), a program office 
within the Office of the Assistant Secretary for Health, Department of 
Health and Human Services (HHS), is soliciting nominations of qualified 
candidates to be considered for appointment as public members to the 
NVAC. The activities of this Committee are governed by the Federal 
Advisory Committee Act (FACA). Management and support services of the 
NVAC and its activities are the responsibility of the NVPO.
    The NVAC serves an advisory role, providing recommendations to the 
Assistant Secretary for Health in his/her capacity as the Director of 
the National Vaccine Program, on matters related to the Program's 
responsibilities. Specifically, the Committee studies and recommends 
ways to encourage the availability of an adequate supply of safe and 
effective vaccination products in the United States; and recommends 
research priorities and other measures to enhance the safety and 
efficacy of vaccines. The Committee also advises the Assistant 
Secretary for Health in the implementation of Sections 2102 and 2103 of 
the PHS Act; and identifies annually the most important areas of 
government and non-government cooperation that should be considered in 
implementing Sections 2102 and 2103 of the PHS Act.

DATES: All nominations for membership on the Committee must be received 
no later than 5:00 p.m. EDT on June 1, 2016, to the address listed 
below.

ADDRESSES: Hardcopy nominations should be mailed or delivered to: Bruce 
Gellin, M.D., M.P.H., Executive Secretary, NVAC, Office of the 
Assistant Secretary for Health, Department of Health and Human 
Services, 200 Independence Avenue SW., Room 715-H, Washington, DC 
20201. Electronic nominations should be emailed to nvpo@hhs.gov.

FOR FURTHER INFORMATION CONTACT: Jennifer Gordon, Ph.D., Alternate 
Designated Federal Official, NVAC; Science Advisor, National Vaccine 
Program Office, Department of Health and Human Services, 200 
Independence Avenue SW., Room 733G, Washington, DC 20201; (202) 260-
6619; Jennifer.Gordon@hhs.gov.
    A copy of the Committee charter which includes the NVAC's structure 
and functions, as well as a list of the current membership, can be 
obtained by contacting Dr. Gordon or by accessing the NVAC Web site at: 
www.hhs.gov/nvpo/nvac.

SUPPLEMENTARY INFORMATION: 
    Committee Function, Qualifications, and Information Required: As 
part of an ongoing effort to enhance deliberations and discussions with 
the public on vaccine and immunization policy, nominations are being 
sought for interested individuals to serve on the NVAC. Committee 
members provide peer review, consultation, advice, and recommendations 
to the Assistant Secretary for Health, in his/her capacity as the 
Director of the National Vaccine Program, on matters related to the 
Program's responsibilities. Individuals selected for appointment to the 
NVAC will serve as voting members. The NVAC consists of 17 voting 
members: 15 public members, including the Chair, and two representative 
members. Individuals selected for appointment to the NVAC can be 
invited to serve terms of up to four years. Selection of members is 
based on candidates' qualifications to contribute to the accomplishment 
of NVAC's objectives. Interested candidates should demonstrate a 
willingness to commit time to NVAC activities and the ability to work 
constructively and effectively on committees.
    Public Members: Public members are individuals who are appointed to 
the NVAC to exercise their own independent, best judgment on behalf of 
the government. It is expected that public members will discuss and 
deliberate in a manner that is free from conflicts of interest. Public 
members to the NVAC shall be selected from individuals who are engaged 
in vaccine research or the manufacture of vaccines, or who are 
physicians, members of parent organizations concerned with 
immunizations, representatives of state or local health agencies, or 
public health organizations.
    Representative Members: Representative members are individuals who 
are appointed to the NVAC to provide the views of industry or a special 
interest group. While they may be experts in various topic areas 
discussed by the Committee, they should not present their own 
viewpoints, but rather those of the industry or special interest group 
they represent. NVAC representative members shall serve specifically to 
represent the viewpoints or perspectives of the vaccine manufacturing 
industry or groups engaged in vaccine research or the manufacture of 
vaccines.
    This announcement is to solicit nominations of qualified candidates 
to fill positions in the public member category of the NVAC, including 
positions that are scheduled to be vacated during the 2016 calendar 
year.
    Travel reimbursement and compensation for services provided to the 
committee: All voting NVAC members, public and representatives, are 
authorized to receive the prescribed per diem allowance and 
reimbursement for travel expenses that are incurred to attend meetings 
and conduct authorized NVAC-related business, in accordance with 
standard government travel regulations. Members appointed to the NVAC 
as public members (see definition above) also are authorized to receive 
a stipend for services provided at public meetings of the Committee. 
All other services that are performed by the public members outside the 
Committee meetings shall be provided without compensation. 
Representative members (see definition above) will serve without 
compensation.
    Expertise sought for the National Vaccine Advisory Committee: In 
accordance with the charter, persons nominated for appointment as 
members of the NVAC should be among authorities knowledgeable in areas 
related to vaccine safety, vaccine effectiveness, and vaccine supply. 
In order to enhance the diversity of expertise included in Committee 
discussions, NVPO is seeking nominations of individuals to serve on the 
NVAC as public members in the following disciplines/topic areas:
     Vaccine research and development, vaccine clinical trials, 
and vaccine regulatory science;
     vaccine safety and post-marketing surveillance;
     vaccine access and financing;
     health information technologies and immunization 
information systems;
     immunization program implementation and management;
     vaccine communications;
    How to submit nominations: Nominations should be typewritten. The 
following information is required to be included in the package of 
material submitted for each individual being nominated for 
consideration: (1) A letter of nomination that clearly states the name 
and affiliation of the nominee, the basis for the nomination (i.e., 
specific attributes which qualify the nominee for service in this 
capacity); and a statement that the nominee is willing to serve as a 
member of the Committee (2) the nominator's name, address and daytime 
telephone number, home and/or work address, telephone number, and email 
address; (3) a copy of the nominee's current curriculum vitae (no 
longer than ten pages); and (4) a short biographical

[[Page 26240]]

sketch (no more than 350 words). All required documentation must be 
received in order for a nomination to be considered. Please note that 
nominees will not receive updates on the status of their nomination. 
Information on nominees appointed to the Committee by the Department 
will be posted to the NVAC Web site (https://www.hhs.gov/nvpo/nvac/roster/). Individuals can nominate themselves for 
consideration of appointment to the Committee. All nominations must 
include the required information. Incomplete nominations will not be 
processed for consideration. The names of federal employees should not 
be nominated for consideration of appointment to this Committee.
    The Department makes every effort to ensure that the membership of 
HHS federal advisory committees is fairly balanced in terms of points 
of view represented and the committee's function. Every effort is made 
that a broad representation of geographic areas, gender, ethnic and 
minority groups, and the disabled are given consideration for 
membership on HHS federal advisory committees. Appointment to this 
Committee shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, disability, and cultural, 
religious, or socioeconomic status.
    Individuals appointed to serve as public members of federal 
advisory committees are classified as special government employees 
(SGEs). SGEs are government employees for purposes of the conflict of 
interest laws. Therefore, individuals appointed to serve as public 
members of NVAC are subject to an ethics review. The ethics review is 
conducted to determine if the individual has any interests and/or 
activities in the private sector that may conflict with performance of 
their official duties as a member of the NVAC. Individuals appointed to 
serve as public members of the NVAC will be required to disclose 
information regarding financial holdings, consultancies, research 
grants and/or contracts, and the absence of an appearance of a loss of 
impartiality.

    Dated: April 25, 2016.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee Deputy 
Assistant Secretary for Health, Director, National Vaccine Program 
Office.
[FR Doc. 2016-10205 Filed 4-29-16; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.